MSP RECOVERY INC (MSPR) Stock Fundamental Analysis

NASDAQ:MSPR • US5537454077

0.2001 USD
-0.06 (-23.07%)
At close: Dec 19, 2025
0.2055 USD
+0.01 (+2.7%)
After Hours: 12/19/2025, 8:04:10 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

MSPR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of MSPR have multiple concerns. MSPR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MSPR had negative earnings in the past year.
  • MSPR had a negative operating cash flow in the past year.
  • In the past 5 years MSPR always reported negative net income.
  • In the past 5 years MSPR reported 4 times negative operating cash flow.
MSPR Yearly Net Income VS EBIT VS OCF VS FCFMSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M -500M

1.2 Ratios

  • MSPR has a Return On Assets of -46.34%. This is amonst the worse of the industry: MSPR underperforms 89.22% of its industry peers.
Industry RankSector Rank
ROA -46.34%
ROE N/A
ROIC N/A
ROA(3y)-6.93%
ROA(5y)-37.77%
ROE(3y)-128.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSPR Yearly ROA, ROE, ROICMSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • MSPR has a Gross Margin of 26.33%. This is comparable to the rest of the industry: MSPR outperforms 53.92% of its industry peers.
  • In the last couple of years the Gross Margin of MSPR has declined.
  • The Profit Margin and Operating Margin are not available for MSPR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5YN/A
MSPR Yearly Profit, Operating, Gross MarginsMSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • MSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MSPR has been reduced compared to 1 year ago.
  • MSPR has less shares outstanding than it did 5 years ago.
  • MSPR has a worse debt/assets ratio than last year.
MSPR Yearly Shares OutstandingMSPR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B
MSPR Yearly Total Debt VS Total AssetsMSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of -2.40, we must say that MSPR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.40, MSPR is doing worse than 87.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.4
ROIC/WACCN/A
WACC0.31%
MSPR Yearly LT Debt VS Equity VS FCFMSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.01 indicates that MSPR may have some problems paying its short term obligations.
  • MSPR has a Current ratio of 0.01. This is amonst the worse of the industry: MSPR underperforms 96.08% of its industry peers.
  • MSPR has a Quick Ratio of 0.01. This is a bad value and indicates that MSPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.01, MSPR is not doing good in the industry: 96.08% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
MSPR Yearly Current Assets VS Current LiabilitesMSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • MSPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.81%.
  • Looking at the last year, MSPR shows a decrease in Revenue. The Revenue has decreased by -8.57% in the last year.
  • MSPR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.65% yearly.
EPS 1Y (TTM)-72.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.93%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y7.65%
Revenue growth 5YN/A
Sales Q2Q%-94.6%

3.2 Future

  • Based on estimates for the next years, MSPR will show a very strong growth in Earnings Per Share. The EPS will grow by 147.54% on average per year.
  • Based on estimates for the next years, MSPR will show a very strong growth in Revenue. The Revenue will grow by 145.11% on average per year.
EPS Next Y145.1%
EPS Next 2Y147.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year197.69%
Revenue Next 2Y145.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MSPR Yearly Revenue VS EstimatesMSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
MSPR Yearly EPS VS EstimatesMSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2K 4K 6K 8K

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • MSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 0.00, which indicates a rather cheap valuation of MSPR.
  • 100.00% of the companies in the same industry are more expensive than MSPR, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, MSPR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0
MSPR Price Earnings VS Forward Price EarningsMSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MSPR Per share dataMSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MSPR's earnings are expected to grow with 147.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y147.54%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MSPR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MSP RECOVERY INC

NASDAQ:MSPR (12/19/2025, 8:04:10 PM)

After market: 0.2055 +0.01 (+2.7%)

0.2001

-0.06 (-23.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-20
Earnings (Next)04-14
Inst Owners0.6%
Inst Owner Change-72.97%
Ins Owners1.34%
Ins Owner Change0%
Market Cap2.85M
Revenue(TTM)9.81M
Net Income(TTM)-719.22M
Analysts82.86
Price TargetN/A
Short Float %2.97%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1702.53
EYN/A
EPS(NY)191.19
Fwd EY95545.98%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-1.21
OCFYN/A
SpS0.69
BVpS-39.57
TBVpS-147.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.33%
FCFM N/A
ROA(3y)-6.93%
ROA(5y)-37.77%
ROE(3y)-128.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.11%
Cap/Sales 5.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -2.4
F-Score2
WACC0.31%
ROIC/WACCN/A
Cap/Depr(3y)1.07%
Cap/Depr(5y)43.68%
Cap/Sales(3y)23.63%
Cap/Sales(5y)15.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.93%
EPS Next Y145.1%
EPS Next 2Y147.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y7.65%
Revenue growth 5YN/A
Sales Q2Q%-94.6%
Revenue Next Year197.69%
Revenue Next 2Y145.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.51%
OCF growth 3YN/A
OCF growth 5YN/A

MSP RECOVERY INC / MSPR FAQ

Can you provide the ChartMill fundamental rating for MSP RECOVERY INC?

ChartMill assigns a fundamental rating of 2 / 10 to MSPR.


What is the valuation status for MSPR stock?

ChartMill assigns a valuation rating of 4 / 10 to MSP RECOVERY INC (MSPR). This can be considered as Fairly Valued.


Can you provide the profitability details for MSP RECOVERY INC?

MSP RECOVERY INC (MSPR) has a profitability rating of 0 / 10.


What is the earnings growth outlook for MSP RECOVERY INC?

The Earnings per Share (EPS) of MSP RECOVERY INC (MSPR) is expected to grow by 145.1% in the next year.